| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection
|
Beaumont, Maribel
|
|
2018
|
4 |
1 |
p. 1-17
|
article
|
| 2 |
ANVISA: an introduction to a new regulatory agency with many challenges
|
Huynh-Ba, Kim
|
|
2018
|
4 |
1 |
p. 1-6
|
article
|
| 3 |
A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
|
Tanguay, Mario
|
|
2018
|
4 |
1 |
p. 1-6
|
article
|
| 4 |
Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
|
Jani, Darshana
|
|
2018
|
4 |
1 |
p. 1-14
|
article
|
| 5 |
Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in Asia-Pacific Economic Cooperation (APEC)
|
Chong, Sannie Siaw Foong
|
|
2018
|
4 |
1 |
p. 1-8
|
article
|
| 6 |
Improving the safety of disposable auto-injection devices: a systematic review of use errors
|
Weinhold, Thomas
|
|
2018
|
4 |
1 |
p. 1-14
|
article
|
| 7 |
Nano-formulations composed of cell membrane-specific cellular lipid extracts derived from target cells: physicochemical characterization and in vitro evaluation using cellular models of breast carcinoma
|
Alharbi, Hanan M.
|
|
2018
|
4 |
1 |
p. 1-9
|
article
|
| 8 |
Stability challenges not addressed by harmonized guidance – AAPS workshop of the stability focus group, April 3rd- 4th, 2017 in Rockville, MD
|
Khan, Mohd M.
|
|
2018
|
4 |
1 |
p. 1-7
|
article
|
| 9 |
The journey to AAPS 2020: a reflection from strategic planning to PharmSci 360
|
Polli, Joseph W.
|
|
2018
|
4 |
1 |
p. 1-4
|
article
|
Journal description